Literature DB >> 19850987

Long-term schisandrin B treatment mitigates age-related impairments in mitochondrial antioxidant status and functional ability in various tissues, and improves the survival of aging C57BL/6J mice.

Kam Ming Ko1, Na Chen, Hoi Yan Leung, Eriol P K Leong, Michel K T Poon, Po Yee Chiu.   

Abstract

Mitochondrial decay is a major cause of aging, leading to the subsequent death of aerobic organisms including humans. In the present study, we examined the effects of supplementation with schisandrin B (Sch B, a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis), administered at 0.012% (w/w) of diet, starting from the age of 36 weeks, on age-dependent changes in mouse mitochondrial antioxidant status and functional ability in various tissues (brain, heart, liver, and kidney) up to the age of 120 weeks. We also monitored survival of male and female C57BL/6J mice. Aging caused progressive impairment in mitochondrial antioxidant status in various tissues, as evidenced by decreases in reduced glutathione and alpha-tocopherol levels, and Mn-superoxide dismutase activity. Impairments in mitochondrial antioxidant status were invariably associated with increases in mitochondria-driven reactive oxygen species (ROS) production in tissue homogenates, as well as decreased mitochondrial ATP-generation capacities (ATP-GCs), in all tested tissues. Diet supplementation with Sch B ameliorated impairment in mitochondrial antioxidant status during aging. The effects were more pronounced in younger than in older mice, when compared to age-matched non-supplemented controls. Sch B supplementation also suppressed mitochondria-driven ROS production and enhanced mitochondrial ATP-GC in various tissues during aging. The beneficial effects of Sch B supplementation on mitochondrial antioxidant status and functional ability were paralleled by survival improvement in aging male mice, when compared with controls. Sch B supplementation also improved the survival in female mice. In conclusion, long-term Sch B supplementation mitigated age-dependent impairments in mitochondrial antioxidant capacity and functional ability, thereby retarding the aging process in mice, particularly during early aging.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19850987     DOI: 10.3233/BIO-2009-1086

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  10 in total

1.  Ursolic-Acid-Enriched Herba Cynomorii Extract Protects against Oxidant Injury in H9c2 Cells and Rat Myocardium by Increasing Mitochondrial ATP Generation Capacity and Enhancing Cellular Glutathione Redox Cycling, Possibly through Mitochondrial Uncoupling.

Authors:  Jihang Chen; Kam Ming Ko
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-10       Impact factor: 2.629

2.  Synergy and Antagonism of Active Constituents of ADAPT-232 on Transcriptional Level of Metabolic Regulation of Isolated Neuroglial Cells.

Authors:  Alexander Panossian; Rebecca Hamm; Onat Kadioglu; Georg Wikman; Thomas Efferth
Journal:  Front Neurosci       Date:  2013-02-20       Impact factor: 4.677

Review 3.  Schisandrin B as a hormetic agent for preventing age-related neurodegenerative diseases.

Authors:  Philip Y Lam; Kam Ming Ko
Journal:  Oxid Med Cell Longev       Date:  2012-05-13       Impact factor: 6.543

Review 4.  Yang/Qi invigoration: an herbal therapy for chronic fatigue syndrome with yang deficiency?

Authors:  Pou Kuan Leong; Hoi Shan Wong; Jihang Chen; Kam Ming Ko
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-11       Impact factor: 2.629

Review 5.  Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress-Protective Activity.

Authors:  Alexander Panossian; Georg Wikman
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-19

6.  Establishment of a comprehensive list of candidate antiaging medicinal herb used in korean medicine by text mining of the classical korean medical literature, "dongeuibogam," and preliminary evaluation of the antiaging effects of these herbs.

Authors:  Moo Jin Choi; Byung Tae Choi; Hwa Kyoung Shin; Byung Cheul Shin; Yoo Kyoung Han; Jin Ung Baek
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-10       Impact factor: 2.629

7.  The immuno-regulatory effects of Schisandra chinensis and its constituents on human monocytic leukemia cells.

Authors:  Rong-Dih Lin; Yi-Wen Mao; Sy-Jye Leu; Ching-Yi Huang; Mei-Hsien Lee
Journal:  Molecules       Date:  2011-06-10       Impact factor: 4.411

Review 8.  Potential of Schisandra chinensis (Turcz.) Baill. in Human Health and Nutrition: A Review of Current Knowledge and Therapeutic Perspectives.

Authors:  Adriana Nowak; Małgorzata Zakłos-Szyda; Janusz Błasiak; Agnieszka Nowak; Zhuo Zhang; Bolin Zhang
Journal:  Nutrients       Date:  2019-02-04       Impact factor: 5.717

9.  Schisandrin B regulates lipid metabolism in subcutaneous adipocytes.

Authors:  Hiu Yee Kwan; Jiahui Wu; Tao Su; Xiao-Juan Chao; Hua Yu; Bin Liu; Xiuqiong Fu; Anfernee Kai Wing Tse; Chi Leung Chan; Wang Fun Fong; Zhi-Ling Yu
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

10.  Schisandrin B attenuates pressure overload-induced cardiac remodeling in mice by inhibiting the MAPK signaling pathway.

Authors:  Fen Ai; Qing-Hao Guo; Bo Yu; Wei Li; Xin Guo; Zhen Chen
Journal:  Exp Ther Med       Date:  2019-10-31       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.